Key Takeaways
- • Cerberus Capital Management has agreed to settle claims from Steward Health Care creditors for an undisclosed amount, with the dollar figure and names of covered parties sealed by court order under the settlement agreement.
- • Creditors alleged Cerberus extracted funds through a 2016 dividend payout while Steward was allegedly insolvent and structured its 2020 exit from the hospital system—which included a loan Cerberus later collected on—in a manner designed to drain value from the company.
- • Steward Health Care filed for Chapter 11 bankruptcy on May 6, 2024, four years after Cerberus exited its stake by selling to a physician-led group headed by CEO Ralph de la Torre in 2020; the system operated 31 hospitals across eight states at bankruptcy filing.
- • Cerberus disputed all creditor allegations, arguing the claims "lacked any merit" and asserting legal defenses on timing grounds that would block recovery, though the firm ultimately agreed to settle without admitting liability or disclosing settlement terms.
- • No formal lawsuit against Cerberus was ever filed; the settlement represents a negotiated resolution to creditor estate claims alleging systematic value extraction during Cerberus's decade-long ownership (2010–2020).
Summary
Cerberus Capital Management has reached a settlement with creditors of Steward Health Care over allegations that the New York-based private equity firm systematically drained funds from the hospital system during and after its ownership period. The settlement amount remains undisclosed, with court orders sealing both the dollar figure and the identities of Cerberus-linked parties covered by the release agreement.
Cerberus held a controlling stake in Steward from 2010 to 2020. The creditor trust—representing Steward's bankruptcy estate following the system's Chapter 11 filing on May 6, 2024—alleged two primary mechanisms of value extraction. First, creditors claimed Cerberus collected a dividend payout in 2016 while Steward was already insolvent, which they characterized as a fraudulent transfer. Second, they alleged the firm structured its 2020 exit from Steward in a manner designed to extract additional value, including through a loan that Cerberus later collected on. The trust also asserted that Steward officers breached fiduciary duties by approving dividends that benefited not only Cerberus but also other company executives.
Cerberus contested all allegations, asserting they "lacked any merit" and citing legal defenses on timing grounds that it claimed would preclude any creditor recovery. Notably, no formal lawsuit against Cerberus was filed; instead, the settlement emerged through negotiated resolution of creditor claims. The firm sold its stake to a physician-led group headed by Steward CEO Ralph de la Torre in 2020. By the time Steward filed for bankruptcy in May 2024, the hospital system operated 31 facilities across eight states.
The settlement represents a conclusion to creditor disputes over value extraction allegations that spanned Cerberus's decade of ownership. The sealed terms and undisclosed settlement amount limit transparency regarding the degree to which creditors recovered losses or the extent of Cerberus's financial exposure in the resolution.
Cerberus held a controlling stake in Steward from 2010 to 2020. The creditor trust—representing Steward's bankruptcy estate following the system's Chapter 11 filing on May 6, 2024—alleged two primary mechanisms of value extraction. First, creditors claimed Cerberus collected a dividend payout in 2016 while Steward was already insolvent, which they characterized as a fraudulent transfer. Second, they alleged the firm structured its 2020 exit from Steward in a manner designed to extract additional value, including through a loan that Cerberus later collected on. The trust also asserted that Steward officers breached fiduciary duties by approving dividends that benefited not only Cerberus but also other company executives.
Cerberus contested all allegations, asserting they "lacked any merit" and citing legal defenses on timing grounds that it claimed would preclude any creditor recovery. Notably, no formal lawsuit against Cerberus was filed; instead, the settlement emerged through negotiated resolution of creditor claims. The firm sold its stake to a physician-led group headed by Steward CEO Ralph de la Torre in 2020. By the time Steward filed for bankruptcy in May 2024, the hospital system operated 31 facilities across eight states.
The settlement represents a conclusion to creditor disputes over value extraction allegations that spanned Cerberus's decade of ownership. The sealed terms and undisclosed settlement amount limit transparency regarding the degree to which creditors recovered losses or the extent of Cerberus's financial exposure in the resolution.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.